Cargando…

Changes in electroencephalography and sleep architecture as potential electrical biomarkers for Alzheimer's disease

Detalles Bibliográficos
Autores principales:	Yu, Hang, Wang, Man-Li, Xu, Xiao-Lan, Zhang, Rong, Le, Wei-Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989997/ https://www.ncbi.nlm.nih.gov/pubmed/33625033 http://dx.doi.org/10.1097/CM9.0000000000001394

Ejemplares similares

A useful electroencephalography (EEG) marker of brain plasticity: delta waves
por: Assenza, Giovanni, et al.
Publicado: (2015)

Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep
por: Levin, Yuval, et al.
Publicado: (2022)

Vascular dysfunction in Alzheimer’s disease: a biomarker of disease progression and a potential therapeutic target
por: Govindpani, Karan, et al.
Publicado: (2019)

Insights from human sleep research on neural mechanisms of Alzheimer’s disease
por: Cordone, Susanna, et al.
Publicado: (2020)

Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
por: Mannu, Piero, et al.
Publicado: (2011)

Non-invasive electrical stimulation as a potential treatment for retinal degenerative diseases
por: Chang, Karen, et al.
Publicado: (2021)

Biomarker-guided drug therapy: personalized medicine for treating Alzheimer’s disease
por: Syal, Charvi, et al.
Publicado: (2021)

How useful are biomarkers for the diagnosis of Alzheimer’s disease and especially for its therapy?
por: Valenza, Marta, et al.
Publicado: (2022)

Clinical application of CSF biomarkers for Alzheimer's disease: From rationale to ratios
por: Bouwman, Femke H., et al.
Publicado: (2022)

Implications of preclinical Alzheimer's disease biomarker disclosure for US policy and society
por: Erickson, Claire M., et al.
Publicado: (2022)

High Density Electroencephalography in Sleep Research: Potential, Problems, Future Perspective
por: Lustenberger, Caroline, et al.
Publicado: (2012)

Consequences of Single-Locus and Tightly Linked Genomic Architectures for Evolutionary Responses to Environmental Change
por: Oomen, Rebekah A, et al.
Publicado: (2020)

Moving beyond disclosure: Stages of care in preclinical Alzheimer's disease biomarker testing
por: Ketchum, Fred B., et al.
Publicado: (2022)

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations
por: Petersen, Ronald C., et al.
Publicado: (2023)

Diagnostic and therapeutic potential of exosomal miRNAs in Alzheimer’s disease
por: Manna, Ida, et al.
Publicado: (2021)

Potential contributions of trace amines in Alzheimer’s disease and therapeutic prospects
por: Dhakal, Sudip, et al.
Publicado: (2020)

Digital technologies as biomarkers, clinical outcomes assessment, and recruitment tools in Alzheimer's disease clinical trials
por: Gold, Michael, et al.
Publicado: (2018)

Graphene-Based Thermal Interface Materials: An Application-Oriented Perspective on Architecture Design
por: Lv, Le, et al.
Publicado: (2018)

The legacy of microbial inoculants in agroecosystems and potential for tackling climate change challenges
por: Liu, Xipeng, et al.
Publicado: (2022)

The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015)

Using Plants as a Source of Potential Therapeutics for the Treatment of Alzheimer’s Disease
por: Maher, Pamela A.
Publicado: (2020)

Is EAAT2 a potential therapeutic intervention target for Alzheimer’s disease?
por: Wood, Oliver WG, et al.
Publicado: (2023)

Telecardiology and Remote Monitoring of Implanted Electrical Devices: The Potential for Fresh Clinical Care Perspectives
por: Boriani, Giuseppe, et al.
Publicado: (2007)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Longitudinal analysis of developmental changes in electroencephalography patterns and sleep-wake states of the neonatal mouse
por: Rensing, Nicholas, et al.
Publicado: (2018)

The tip of the iceberg? The underestimated potential of non-canonical beta-amyloids for Alzheimer’s disease
por: Busch, Lukas, et al.
Publicado: (2023)

Electroencephalography for Early Detection of Alzheimer’s Disease in Subjective Cognitive Decline
por: Shim, YongSoo, et al.
Publicado: (2022)

Pyrroles as a Potential Biomarker for Oxidative Stress Disorders
por: Lambert, Brett, et al.
Publicado: (2023)

Diagnosis of Alzheimer’s disease with Electroencephalography in a differential framework
por: Houmani, Nesma, et al.
Publicado: (2018)

Streptozotocin induced Alzheimer's disease like changes and the underlying neural degeneration and regeneration mechanism
por: Kamat, Pradip Kumar
Publicado: (2015)

Mens sana in corpore sano: lifestyle changes modify astrocytes to contain Alzheimer’s disease
por: Augusto-Oliveira, Marcus, et al.
Publicado: (2021)

Prothrombin kringle-2, a mediator of microglial activation: new insight in Alzheimer’s disease pathogenesis
por: Lee, Jae Man, et al.
Publicado: (2022)

Heparan sulfate proteoglycans and heparanases in Alzheimer's disease: current outlook and potential therapeutic targets
por: Lorente-Gea, Laura, et al.
Publicado: (2017)

Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing
por: Fessel, Jeffrey
Publicado: (2021)

Therapeutic potential of alpha 5 subunit containing GABA(A) receptors in Alzheimer’s disease
por: Kwakowsky, Andrea, et al.
Publicado: (2021)

Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimer´s disease
por: Fernández-Vega, Iván, et al.
Publicado: (2020)

Misfolded amyloid-β strains and their potential roles in the clinical and pathological variability of Alzheimer’s disease
por: Kelley, Sara, et al.
Publicado: (2022)

Novel bifunctional cap for simultaneous electroencephalography and transcranial electrical stimulation
por: Wunder, Sophia, et al.
Publicado: (2018)

Electroencephalography-driven approach to prodromal Alzheimer’s disease diagnosis: from biomarker integration to network-level comprehension
por: Moretti, Davide Vito
Publicado: (2016)

Electroencephalography as a Non-Invasive Biomarker of Alzheimer’s Disease: A Forgotten Candidate to Substitute CSF Molecules?
por: Monllor, Paloma, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7rdt1cb4kjh0bsth8j5sl6v25i